Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05018364
Other study ID # MS-222-2020
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 1, 2020
Est. completion date June 15, 2021

Study information

Verified date August 2021
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is to evaluate brain and kidney injuries in full-term neonates with perinatal asphyxia by detecting specific biomarker in blood (Erythropoietin).


Description:

Perinatal hypoxic-ischemic encephalopathy (HIE) is an important cause of brain injury in the newborn and can result in long-term devastating consequences. Acute kidney injury (AKI) occurs in (50 - 72%) among asphyxiated term infants. The kidney cells that make erythropoietin are sensitive to low oxygen levels in the blood that travels through the kidney. These cells make and release erythropoietin when the oxygen level is too low.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date June 15, 2021
Est. primary completion date June 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 4 Days
Eligibility Inclusion Criteria: Cases group: 1. The presence of a sentinel hypoxic event immediately before or during delivery 2. History of fetal distress (bradycardia, late decelerations, absence of heart rate variability). 3. Need for neonatal resuscitation at delivery 4. One-min Apgar score <3 or 5-minApgar score<7 5. Metabolic acidosis (BE > 10 in cord blood) 6. Cardiocirculatory instability (CCI), clinical indications of hypoxic-ischemic encephalopathy (HIE) and multiple organ involvement (MOI). Control group: Newborns who were delivered normally after uncomplicated pregnancy. None of them have clinical nor biochemical signs of asphyxia. Exclusion Criteria: - Newborns who do not fulfill the above criteria. - Newborns with congenital heart diseases and perinatal hemolytic anemia or congenital liver affection. - Whose parents refuse to participate in the study. - Cases above 4 days old. - Preterm neonates (less than 37 weeks).

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Serum erythropoietin level
Evaluate serum erythropoietin level in neonates exposed to hypoxia compared to control group

Locations

Country Name City State
Egypt faculty of medicine, Cairo university Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Sweetman DU, Onwuneme C, Watson WR, Murphy JF, Molloy EJ. Perinatal Asphyxia and Erythropoietin and VEGF: Serial Serum and Cerebrospinal Fluid Responses. Neonatology. 2017;111(3):253-259. doi: 10.1159/000448702. Epub 2016 Dec 1. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary correlation between serum erythropoietin level and brain injury measure level of serum erythropoietin by ELISA technique and test if can differentiate degree of brain hypoxia first 4 days of life
See also
  Status Clinical Trial Phase
Completed NCT03407729 - Measuring Brain Activity of School Age Children
Not yet recruiting NCT04913324 - Early Virtual Intervention for Infants With CP Following HIE Diagnosis N/A